Neurophysiological effects of buspirone and isapirone in the hippocampus: comparison with 5-hydroxytryptamine

Beck, 1985, Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slice in vitro, European J. Pharmacol., 116, 195, 10.1016/0014-2999(85)90206-7 Dompert, 1985, 3H-TVX Q 7821: identification of 5-HT binding sites as target for a novel putative anxiolytic, Naunyn-Schmiedeb. Arch. Pharmacol., 328, 467, 10.1007/BF00692918 Goldberg, 1984, Buspirone hydrochloride: a unique new anxiolytic agent, J. Clin. Psychiat., 43, 87 Gray, 1982 Peroutka, 1985, Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors, Biol. Psychiat., 20, 971, 10.1016/0006-3223(85)90194-5 Rowan, 1985, The effect of prolonged treatment with tricyclic antidepressants on the actions of 5-hydroxytryptamine in the hippocampal slice of the rat, Neuropharmacology, 24, 131, 10.1016/0028-3908(85)90172-8 Skolnick, 1985, Monoaminergic involvement in the pharmacological actions of buspirone, Br. J. Pharmacol., 86, 637, 10.1111/j.1476-5381.1985.tb08940.x Trulson, 1986, Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurones in-vitro, J. Pharm. Pharmacol., 38, 380, 10.1111/j.2042-7158.1986.tb04591.x Verge, 1985, Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype, European J. Pharmacol., 113, 463, 10.1016/0014-2999(85)90099-8 Wolf, 1977, Effects of benzodiazepines and barbiturates on hippocampal recurrent inhibition, Naunyn-Schmiedeb. Arch. Pharmacol., 299, 211, 10.1007/BF00500313